ALK-Positive Anaplastic Large Cell Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB14776Camrelizumab1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00997Doxorubicin1 / 2Recruiting1
DB00480Lenalidomide1 / 2Recruiting1
DB00635Prednisone1 / 2Recruiting1
DB00073Rituximab1 / 2Recruiting1
DB14765Rivoceranib1 / 2Recruiting1
DB14922Tislelizumab1 / 2Recruiting1
DB15043Toripalimab1 / 2Recruiting1
DB00541Vincristine1 / 2Recruiting1
DB14922Tislelizumab2Active Not Recruiting1
DB08865Crizotinib4Recruiting1
DB00773Etoposide4Recruiting1